Top compounds associated with response to TMA7


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA myricetin CTRPv2 pan-cancer AAC 0.065 0.1
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.05 0.1
mRNA MST-312 CTRPv2 pan-cancer AAC 0.059 0.1
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.19 0.1
mRNA LY-2157299 CTRPv2 pan-cancer AAC -0.13 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.1
mRNA staurosporine CTRPv2 pan-cancer AAC -0.13 0.1
mRNA brivanib CTRPv2 pan-cancer AAC 0.058 0.1
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.053 0.1
Download CSV